TY1 functions by suppressing excessive activation of the cGAS‑STING pathway induced by DNA damage, thereby dampening inflammatory signals and reversing fibrosis. However, if the root cause of DNA damage is not eliminated, new DNA damage will continue to emerge after the drug is metabolized, progressing into fibrosis once again. Definitive treatment must remove the root cause. This limitation of TY1 can be deduced through logical reasoning. The function of logic is described in the attached text.https://t.co/kKupNw4B1h
#TY1 exerts its effect by inhibiting the overactivation of the #cGAS‑STING pathway triggered by DNA damage, reducing inflammatory signaling and reversing #fibrosis. Nevertheless, failure to eliminate the root source of DNA damage will lead to continuous generation of new #DNA damage after drug clearance, which will further drive the progression of fibrosis. Curative treatment must eradicate the underlying root cause. This drawback of TY1 can be derived via logical inference. The role of logic is elaborated in the attached article.https://t.co/kKupNw4B1h
Excited to share our latest paper in @JCI_insight, with @XMichaelJonesMD & @TheIbrahimLab : #TY1, an #RNA #exomer drug, reverses the key disease manifestations of #scleroderma in 2 mouse models & in human #SSc cells. The drug works well orally & has unprecedented disease-modifying bioactivity in this horrible disease. Next step: clinical trials!
https://t.co/0EXDWd7CqI
@ChristianRolfo Regardless of an expert’s stature, overlooking the root causes of disease onset and pathological changes means they possess no real logical reasoning — they are nothing but walking bookshelves. See attachment for what logic can accomplish.https://t.co/PFY2KRCzT8
No matter how distinguished an expert may be, if they overlook the #root causes of disease onset and #pathological changes, they lack logical thinking ability and are merely a walking bookshelf. For what logic can achieve, see the attached document for reasoning.https://t.co/kKupNw4B1h
We’re recruiting Medical Oncologists to join an exceptional team at a leading academic institution. Opportunities across all tumor types, in both outpatient & inpatient care, with a focus on clinical excellence, education & innovation.Join us in shaping the future of cancer care.
Humans have a natural lifespan of 120 years. Various assaults to the body over time shorten this limit substantially. Any agent that reduces these assaults may ultimately slow aging. Targeted treatment is essential; misaligned intervention can cause bodily harm. This is a perspective from traditional Chinese medicine.
Human beings are endowed with a natural lifespan of 120 years. Over the long course of life, the human body sustains diverse assaults, which ultimately result in a lifespan far shorter than 120 years. It can be stated that any medicine capable of reducing such assaults upon the human body will ultimately delay aging. Targeted intervention is critical; inappropriate intervention may inflict harm on the human body. This is a viewpoint of #TCM.
My dear friends, I am happy to report the publication of the most important paper in my life to date (we have several great papers coming out but this is very special). Tomorrow, I will present this paper for the first time at the Nature AI Healthcare in Paris and will post a longer post on this story and its broader implications for how to conduct clinical trials. Please read it and comment on it.
Many thanks to the great co-authors of the study and everyone who contributed. Many thanks to the many reviewers (friendly and unfriendly) for spending so much time and helping make it better.
Link in the comments.
Once the #cancer‑cell production line is built, it makes no fundamental difference whether it produces one cancer cell or ten billion. Real treatment is to dismantle the production line, not just kill cancer cells. This kind of testing misses the core issue. Such thinking is still primitive. See attachment for reasoning.https://t.co/0op4kd7ysK
Once the #cancer‑cell production line is assembled, there is essentially no difference whether it generates one cancer cell or ten billion cancer cells. True treatment lies in dismantling this production line, not merely eliminating cancer cells. Such testing fails to grasp the key point. This line of thinking remains primitive. See the attached document for reasoning.https://t.co/0op4kd7ysK
This study shows functionally active lymphoid aggregates in brain metastatic lesions correlate with better patient outcomes. These immune‑cell clusters trigger anti‑tumor immune responses and are vital biomarkers for the brain‑metastasis immune microenvironment. Why do such active lymphoid aggregates form in some metastases? What is their root cause? What is the root cause of brain metastases? Without solving these questions, treatment will stay primitive. See attachment for reasoning.https://t.co/0op4kd7ysK
This study finds that functionally active lymphoid aggregates within brain metastatic lesions are associated with better patient prognosis. These immune‑cell aggregates can initiate anti‑tumor immune responses and serve as key biomarkers for the immune microenvironment of brain metastases. Why do functionally active lymphoid aggregates emerge in some metastatic lesions? What is their root cause? What is the root cause of brain metastases? Without answers to these questions, therapeutic approaches will remain stuck in a primitive mindset. See the attached document for reasoning.https://t.co/0op4kd7ysK
Now online in @CD_AACR: Functionally Active Lymphoid Aggregates Correlate with Improved Prognosis in Brain Metastases - by Noor Nader, Xiaoran Zhang, @BcellBruno, and colleagues @pitt_immunology@PittNeurosurg
Tumor sequencing today picks up numerous mutations, but these are just downstream outcomes. Without eliminating the root cause behind them, fixing these mutations and their effects is temporary. After drugs are metabolized, fresh mutations keep appearing. This therapeutic thinking is still primitive. See attachment for reasoning.https://t.co/1QmDkQtSQl
#Tumor#sequencing today can detect a host of mutations, yet these #mutations themselves are merely outcomes. If the root cause that gives rise to these outcomes is not eliminated, correcting these mutations and their downstream effects will only be temporary. Once the drugs are metabolized, new mutations will continue to emerge. Such a therapeutic mindset remains in a primitive state. See the attached document for reasoning.https://t.co/1QmDkQtSQl
ICYMI in @CD_AACR: A Foundation Model of Cancer Genotype Enables Precise Predictions of Therapeutic Response - by JungHo Kong, @zhenwang9102, @TreyIdeker, and colleagues @UCSanDiego
#Germline#DICER1#mutations predispose children to multiple cancers, yet their underlying mechanism has long remained a mystery. In fact, this is not unique to this disease: the root cause remains elusive for all chronic diseases. Germline DICER1 mutations are not the true root cause; what gives rise to these mutations is the real underlying origin. Here we are referring to the root cause, not the direct cause. Such a line of thinking is still in a primitive state. See the attached document for reasoning.https://t.co/0op4kd7ysK
🧬 Germline DICER1 mutations predispose children to multiple cancers, but the mechanism was a mystery. New research reveals these mutations may drive tumor development by recruiting a whole family of neutrophils. 🔬
👇Learn more here👇
https://t.co/TiSZVbMC04
AI can accelerate research by focusing on #target identification and therapeutic development. However, if the target is not the #root cause, correcting the target‑related abnormalities will still lead to the continuous emergence of new target‑associated aberrations. See the attached document for reasoning.https://t.co/1QmDkQtSQl
Congratulations @NatureRevCancer on 25 years!
In this Viewpoint, six of us reflect on the past quarter century of cancer research and on where the field is heading
I write about agentic AI and human-AI co-science, and what it takes for them to work in cancer research
https://t.co/ozzqOV4Wvs
#Cancer#immunotherapy modulates and mobilizes the body’s own immune system to recognize and eliminate tumors by overcoming #tumor immune escape. Yet it still relies on the immune system to kill cancer cells. If the root cause is not eliminated, new cancer cells will keep emerging once the current drugs are metabolized. True treatment lies in eradicating the root cause. See the attached document for details.https://t.co/1QmDkQtSQl
We congratulate former AACR President and #AACRFellows Antoni Ribas, recipient of the 2026 ESMO Lifetime Achievement Award. The award honors his pioneering contributions to cancer immunotherapy and translational cancer research.
https://t.co/3ScafhivZK
Identifying the root cause of disease is unavoidable. Otherwise, American medicine would remain in its primitive state, as elaborated in the attached document.https://t.co/g1aQKMC9Vj
In my Director's Message in @theNCI's FY28 Annual Plan, I lay out a patient-centered vision for the future of cancer research—a vision built on harnessing AI, speeding up trials, and supporting innovative research. Where do you see the biggest opportunity? https://t.co/73KZzKVz5H
@NaturopathNews What we call "precision" is merely precision in the location, layer, and size of the lesion—not precision in addressing the root cause. True treatment means eliminating the root cause; otherwise, new lesions will keep forming.
@GENbio What we call "precision" is merely precision in the location, layer, and size of the lesion—not precision in addressing the root cause. True treatment means eliminating the root cause; otherwise, new lesions will keep forming.
@WCMEnglanderIPM@Degreesofhealth What we call "precision" is merely precision in the location, layer, and size of the lesion—not precision in addressing the root cause. True treatment means eliminating the root cause; otherwise, new lesions will keep forming.
@LurieCancer@theabzlab@NUFeinbergMed What we call "precision" is merely precision in the location, layer, and size of the lesion—not precision in addressing the root cause. True treatment means eliminating the root cause; otherwise, new lesions will keep forming.